ID

33476

Description

Study ID: 107806 Clinical Study ID: RA3107806 Study Title: An open label study to determine the safety, tolerability, excretion balance and pharmacokinetics of Losmapimod, administered as a single dose of an oral solution to healthy adult male subjects Patient Level Data: Clinicaltrials.gov Identifier: NCT00599612 https://clinicaltrials.gov/ct2/show/NCT00599612 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: losmapimod Trade Name: losmapimod Study Indication: Pulmonary Disease, Chronic Obstructive The study consists of a screening, study visit and follow-up. The protocol identifier for all: RA3107806 This document contains the investigational product and treatment confirmation form. It has to be filled in for study visit.

Lien

https://clinicaltrials.gov/ct2/show/NCT00599612

Mots-clés

Versions (3)

1. 04/12/2018 04/12/2018 -
2. 07/12/2018 07/12/2018 -
3. 10/12/2018 10/12/2018 - Sarah Riepenhausen

Détendeur de droits

GlaxoSmithKline

Téléchargé le

10 décembre 2018

DOI

Pour une demande vous connecter.

Licence